- Home
- BZUN vs TARA Comparison
BZUN vs TARA Comparison
Compare BZUN & TARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BZUN
- TARA
- Stock Information
- Founded
- BZUN 2007
- TARA N/A
- Country
- BZUN China
- TARA United States
- Employees
- BZUN N/A
- TARA N/A
- Industry
- BZUN Catalog/Specialty Distribution
- TARA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BZUN Consumer Discretionary
- TARA Health Care
- Exchange
- BZUN Nasdaq
- TARA Nasdaq
- Market Cap
- BZUN 188.7M
- TARA 202.8M
- IPO Year
- BZUN N/A
- TARA N/A
- Fundamental
- Price
- BZUN $2.88
- TARA $4.55
- Analyst Decision
- BZUN Strong Buy
- TARA Strong Buy
- Analyst Count
- BZUN 3
- TARA 3
- Target Price
- BZUN $3.20
- TARA $22.67
- AVG Volume (30 Days)
- BZUN 475.0K
- TARA 523.2K
- Earning Date
- BZUN 11-21-2024
- TARA 03-12-2025
- Dividend Yield
- BZUN N/A
- TARA N/A
- EPS Growth
- BZUN N/A
- TARA N/A
- EPS
- BZUN N/A
- TARA N/A
- Revenue
- BZUN $1,312,737,613.00
- TARA N/A
- Revenue This Year
- BZUN $8.16
- TARA N/A
- Revenue Next Year
- BZUN $4.71
- TARA N/A
- P/E Ratio
- BZUN N/A
- TARA N/A
- Revenue Growth
- BZUN 7.26
- TARA N/A
- 52 Week Low
- BZUN $1.92
- TARA $1.60
- 52 Week High
- BZUN $4.38
- TARA $10.48
- Technical
- Relative Strength Index (RSI)
- BZUN 50.72
- TARA 41.78
- Support Level
- BZUN $2.75
- TARA $5.04
- Resistance Level
- BZUN $2.88
- TARA $6.20
- Average True Range (ATR)
- BZUN 0.15
- TARA 0.40
- MACD
- BZUN -0.02
- TARA -0.22
- Stochastic Oscillator
- BZUN 53.33
- TARA 2.37
About BZUN Baozun Inc.
Baozun Inc is an e-commerce service partner that helps brands execute their e-commerce strategies in China by selling their goods directly to customers online or by providing services to assist with their e-commerce operations. Its integrated end-to-end e-commerce service capabilities, omni-channel expertise, and technology-driven solutions. Company have two operating segments namely E-Commerce (including BEC and BZI) and Brand Management (BBM).
About TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops, and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).